Skip to main content

hydrocortisone sodium phosphate (Softacort®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name hydrocortisone sodium phosphate (Softacort®)
Formulation 3.35 mg/ml eye drops
Reference number 3592
Indication

Treatment of mild non-infectious allergic or inflammatory conjunctival diseases

Company Thea Pharmaceuticals Ltd.
BNF chapter Eye
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 04/09/2019
Follow AWTTC: